If health and wellness was on an upward trend before, the pandemic has accelerated that as people have become more conscious of the toll that certain food, drink and activities, or lack thereof, can have on the human body. As a result of COVID-19, this consciousness has exploded. From what we touch to where food comes from, awareness of the benefits of cutting bad habits and improving the overall health of people and planet is booming.

Aceto is a key company helping to fuel this health-centric global trend. Founded in 1947, it has been a stalwart in the global ingredients and life science industry for decades, distributing and manufacturing key compounds and ingredients principally used by the pharmaceutical and nutraceutical industries. Its success has come from providing valuable solutions to global problems, acting as a significant supplier of difficult-to-source materials at fair prices.

Tailor-made is better

In 2019, the company was acquired by New Mountain Capital, a New York-based investment firm with a keen eye for growth opportunities. Indeed, under its new ownership, the plan is to double Aceto’s current annual revenue by 2024 through both organic expansion and acquisitions. Aceto’s Nutritional Business Unit will play a major role in achieving this ambitious target. Currently present in Europe, the US and South East Asia, the company serves 400 global customers with approximately 250 products. It has one of the largest omega-3 oils and powder portfolios in Europe, while also holding major positions in amino acids, vitamins such as coenzyme Q10, proteins including lactoferrins, and a large panel of botanical extracts. Key to Aceto’s longevity  has been a localised approach.

Despite serving hundreds of companies in numerous markets globally, the company meets the bespoke needs of different countries with tailored product offerings. Indeed, its customers play a significant role in moulding its offering, the firm working consistently and tirelessly to understand their present and future requirements so that it may meet those specific needs. This equally facilitates an ingrained focus on quality. While it may be less costly to outsource production to the cheapest bidder, Aceto chooses to support local innovators in regional markets that provide differentiated products. The result is a transparent portfolio backed by proven local suppliers and products with demonstrable benefits supported by scientific data. Its partnerships are vital, a key example in the nutrition segment being its ties with Progress Biotech, a company that provides DHA algae that is extremely high in purity and almost tasteless—a rarity given the product in question.

2022 and beyond

Strengthening such relationships is an ongoing focus for Aceto, as the company is in the midst of preparations for a transparency audit that will further bolster its portfolio of proven products within the global market. Attention has also turned to new opportunities. After observing interesting developments in vitamins K2, K6 and K2MK7 in recent times, Aceto will be re-entering the vitamins segment following almost a decade away from the space. It has recently signed an agreement with an Indian partner on L5 methyl folate calcium that will add another new dimension to its offering. Numerous other plans have also come to the fore as the company pursues significant growth. It will additionally be launching more specialised products like a nitrous, granulated form of quercetin that has been gaining traction because of its immune system health benefits. And attention will further be turned towards digital improvements, including a website revamp and a groundbreaking ecommerce model within the next 12 to 24 months. Indeed, as a result of these concurrent emphases on localisation, key partnerships, expansion, acquisitions, data-proven products, new nutritional products and digital initiatives, the company looks set to take great strides on its growth journey.

Learn more about Aceto at www.aceto.com